For example, in a retrospective analysis patients with mild cognitive impairment, rivastigmine, which inhibits both AChE and butyrylcholinesterase (BChE, EC 3.1.1.8) [53], reduces whole brain atrophy, hippocampal atrophy, and white matter loss [54]. The gene discussed is ACHE; the disease is hippocampal atrophy.